SUBSCRIBERS
Wild swings in Biolidics' shares after news of Covid-19 test kit deal
Add BT as a preferred source
Published Thu, Apr 23, 2020 · 09:50 PM
Singapore
SHARES of Biolidics rapidly lost the bulk of their gains accumulated from recent days, after the medtech firm announced that Nasdaq-listed Aytu Bioscience will be the exclusive distributor of its Covid-19 rapid test kit in the United States.
The frenzied trading kicked off at 3.30pm on Thursday once Biolidics' trading halt was lifted, and proceeded to set off the Singapore Exchange's (SGX) circuit breaker at least once in the final hour of trading.
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Copyright SPH Media. All rights reserved.
